Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation

View this record at source repository
Description:
The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.
Author(s):
Health Canada

Health Canada

Source Repository:
Canadian Urban Data Catalogue
Publisher(s):
Health Canada
Access:
Public
License:
Open Government Licence - Canada https://open.canada.ca/en/open-government-licence-canada
URL:
https://data.urbandatacentre.ca/dataset/cc1a507b-240e-47fc-812e-49f442854890
Publication date:
2023-01-11
Keywords:
Health and Safety, drug submissions, management-of-rolling reviews, cancellation, and performance targets-and-standards
Identifier:
https://data.urbandatacentre.ca/dataset/cc1a507b-240e-47fc-812e-49f442854890

Geospatial information

There is no geographic information available for this record.
Select geospatial feature(s) to view on map:
View this record at source repository
Note: Up to 1000 features for each file are displayed

Citation

APA Citation:
Canada, H. (2023). Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation [Data set]. Canadian Urban Data Catalogue. https://data.urbandatacentre.ca/dataset/cc1a507b-240e-47fc-812e-49f442854890
Citation copied to clipboard
Export to citation manager: